Exelixis, Inc. (EXEL) - NASDAQ
From other sites
Company Description
Exelixis, Inc. is a biopharmaceutical company, which engages in the developing and commercializing small molecule therapies for the treatment of cancer. Its two advanced assets are COMETRIQ and cobimetinib. The company focuses on their proprietary resources and development and commercialization... More
Sector: Healthcare
Industry: Biotechnology
Country: United States